Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Saline Placebo | Control patients will receive intranasal saline saline placebo: intranasal saline given as placebo | 0 | None | 0 | 14 | 0 | 14 | View |
| Nasal Midazolam Only | Patients will receive 0.2 mg/kg of intranasal midazolam Midazolam: midazolam 0.2 mg/kg given intranasally | 0 | None | 0 | 14 | 0 | 14 | View |
| Midazolam Plus Xylocaine | Patients will receive 0.2 mg/kg intranasal midazolam plus xylocaine 4% in a dose based on 50% of the volume of the midazolam. Midazolam: midazolam 0.2 mg/kg given intranasally xylocaine: intransal xylocaine given in conjunction with intranasal midazolam | 0 | None | 0 | 14 | 0 | 14 | View |